Immunomedics, Inc.
-
Ticker
IMMU
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 51-200 Employees
- Based in Morris Plains, New Jersey
Immunomedics, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and marketing of monoclonal, antibody-based products for the treatment of cancer, autoimmune, and other serious diseases in the United States and Europe.
Immunomedics, Inc.
Most Recent Annual Report
MOST RECENT
2019 Annual Report and Form 10K
Older/Archived Annual Reports